Neela Therapeutics raised $13.82 million to advance its pipeline of pediatric medicines for the treatment of rare neurodevelopmental and neurodegenerative disorders, including CLN3 Batten disease and Rett syndrome.
Neela Therapeutics raised $13.82 million to advance its pipeline of pediatric medicines for the treatment of rare neurodevelopmental and neurodegenerative disorders, including CLN3 Batten disease and Rett syndrome.